HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Thierry Arnould Selected Research

Neoplasms (Cancer)

1/2020MPV17 does not control cancer cell proliferation.
5/2015Lipin-1 regulates cancer cell phenotype and is a potential target to potentiate rapamycin treatment.
5/2015Taxol-induced unfolded protein response activation in breast cancer cells exposed to hypoxia: ATF4 activation regulates autophagy and inhibits apoptosis.
1/2015Heat-modified citrus pectin induces apoptosis-like cell death and autophagy in HepG2 and A549 cancer cells.
9/2014Unraveling biochemical pathways affected by mitochondrial dysfunctions using metabolomic approaches.
12/2013Differential effect of hypoxia on etoposide-induced DNA damage response and p53 regulation in different cell types.
9/2012TMEM45A is essential for hypoxia-induced chemoresistance in breast and liver cancer cells.
1/2012Hypoxia-induced modulation of apoptosis and BCL-2 family proteins in different cancer cell types.
10/2010BNIP3 protects HepG2 cells against etoposide-induced cell death under hypoxia by an autophagy-independent pathway.
1/2009Up-regulation of cathepsin B expression and enhanced secretion in mitochondrial DNA-depleted osteosarcoma cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Thierry Arnould Research Topics

Disease

10Neoplasms (Cancer)
01/2020 - 01/2009
6Mitochondrial Diseases (Mitochondrial Disease)
01/2019 - 06/2005
6Hypoxia (Hypoxemia)
05/2015 - 10/2010
4Obesity
02/2018 - 01/2009
2Carcinogenesis
04/2015 - 01/2009
2Nervous System Diseases (Neurological Disorders)
09/2014 - 06/2012
2Atherosclerosis
01/2013 - 11/2010
2Inflammation (Inflammations)
06/2012 - 01/2011
2Hypersensitivity (Allergy)
01/2012 - 05/2011
2MERRF Syndrome (Myoclonic Epilepsy and Ragged Red Fibers)
01/2012 - 06/2005
2Hepatocellular Carcinoma (Hepatoma)
10/2010 - 02/2004
1Type 1 Diabetes Mellitus (Autoimmune Diabetes)
11/2018
1Hypertrophy
02/2018
1Weight Loss (Weight Reduction)
01/2018
1Body Weight (Weight, Body)
01/2018
1Breast Neoplasms (Breast Cancer)
05/2015
1Infections
04/2015
1Bacterial Infections (Bacterial Infection)
04/2015
1Dyslipidemias (Dyslipidemia)
01/2013
1Insulin Resistance
01/2013
1Atherosclerotic Plaque (Atheroma)
01/2013
1Lysosomal Storage Diseases (Lysosomal Storage Disease)
12/2012
1Tauopathies
06/2012
1Alzheimer Disease (Alzheimer's Disease)
06/2012
1Neurodegenerative Diseases (Neurodegenerative Disease)
06/2012
1Starvation
01/2012
1MELAS Syndrome (Syndrome, MELAS)
01/2012
1B-Cell Lymphoma (Lymphoma, B Cell)
05/2011
1Lymphoma (Lymphomas)
05/2011
1Asthma (Bronchial Asthma)
01/2011
1Osteosarcoma (Osteogenic Sarcoma)
01/2009
1Multiple Symmetrical Lipomatosis (Lipomatosis, Familial Benign Cervical)
06/2005
1Mitochondrial cytopathy
06/2005
1Fibrosarcoma
04/2004
1Cholestasis
10/2003
1Necrosis
10/2003

Drug/Important Bio-Agent (IBA)

6Etoposide (VP 16)FDA LinkGeneric
04/2015 - 10/2010
5Proteins (Proteins, Gene)FDA Link
12/2013 - 01/2009
4Mitochondrial DNA (mtDNA)IBA
01/2020 - 01/2009
4LipidsIBA
01/2013 - 01/2009
3Triglycerides (Triacylglycerol)IBA
02/2018 - 06/2005
3MicroRNAs (MicroRNA)IBA
04/2015 - 01/2011
2Small Interfering RNA (siRNA)IBA
01/2020 - 10/2010
2Biomarkers (Surrogate Marker)IBA
05/2015 - 09/2012
2Paclitaxel (Taxol)FDA LinkGeneric
05/2015 - 09/2012
2CalciumIBA
04/2015 - 01/2012
2Reactive Oxygen Species (Oxygen Radicals)IBA
09/2014 - 01/2009
2DNA (Deoxyribonucleic Acid)IBA
09/2014 - 04/2006
2StaurosporineIBA
01/2012 - 05/2011
2Caspase 3 (Caspase-3)IBA
01/2012 - 05/2011
2Cathepsin BIBA
05/2011 - 01/2009
1Mitochondrial Uncoupling ProteinsIBA
01/2019
1Hormones (Hormone)IBA
11/2018
1ApelinIBA
01/2018
1alpha-MSHIBA
01/2018
1CarboxypeptidasesIBA
01/2018
1Propranolol (Inderal)FDA LinkGeneric
05/2015
1Sirolimus (Rapamycin)FDA Link
05/2015
1Pattern Recognition ReceptorsIBA
04/2015
1Pathogen-Associated Molecular Pattern MoleculesIBA
04/2015
1citrus pectinIBA
01/2015
1PectinsIBA
01/2015
1Protein AggregatesIBA
09/2014
1Adenosine Triphosphate (ATP)IBA
09/2014
1Insulin (Novolin)FDA Link
01/2013
1Fenofibrate (CiL)FDA LinkGeneric
01/2013
1LDL Receptors (LDL Receptor)IBA
01/2013
1Rosiglitazone (Avandia)FDA Link
01/2013
1Peroxisome Proliferator-Activated Receptors (PPAR)IBA
01/2013
1AdiponectinIBA
01/2013
1tau Proteins (tau Protein)IBA
06/2012
1quinone (benzoquinone)IBA
01/2012
1Cytochromes c (Cytochrome c)IBA
01/2012
1Heme Oxygenase-1IBA
01/2012
1Oxidoreductases (Dehydrogenase)IBA
01/2012
1Pharmaceutical PreparationsIBA
01/2012
1CaspasesIBA
01/2012
1NAD (NADH)IBA
01/2012
1Messenger RNA (mRNA)IBA
01/2011
1Matrix Metalloproteinases (MMPs)IBA
01/2011
1Biological ProductsIBA
01/2011
1OvalbuminIBA
01/2011
1oxidized low density lipoproteinIBA
11/2010
1LDL Lipoproteins (beta Lipoproteins)IBA
11/2010
1heparanaseIBA
01/2009
1NF-kappa B (NF-kB)IBA
01/2009
1HydrolasesIBA
01/2009
1Peptide Hydrolases (Proteases)FDA Link
01/2009
1Glucose (Dextrose)FDA LinkGeneric
06/2005
1Fatty Acids (Saturated Fatty Acids)IBA
06/2005
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
04/2004
1tert-ButylhydroperoxideIBA
02/2004
1Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
10/2003

Therapy/Procedure

5Therapeutics
05/2015 - 10/2010
5Drug Therapy (Chemotherapy)
05/2015 - 01/2012
1Bariatric Surgery
01/2018